prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype Her2, Specimen #: Race: WHITE. Physician (s) : AMENDED. SPECIMEN: A: LEFT BREAST TISSUE B: SENTINEL NODE LEFT AXILLARY. FINAL DIAGNOSIS: A. BREAST, LEFT, EXCISIONAL BIOPSY. - INFILTRATING DUCTAL CARCINOMA, NO SPECIAL TYPE. -NOTTINGHAM GRADE: III/III, POORLY DIFFERENTIATED. -NOTTINGHAM SCORE: 8/9 (TUBULES=3, MITOSES=2, NUCLEI=3). -TUMOR SIZE: 3.1 CM (MEASURED GROSSLY, SEE COMMENT) . - TUMOR NECROSIS: ABSENT. - -MICROCALCIFICATIONS: ABSENT. - LYMPHVASCULAR INVASION: NO UNEQUIVOCAL INVOLVEMENT. -MARGINS: : NEGATIVE. - INTRADUCTAL COMPONENT: LESS THAN 25%, WITH PROMINENT CANCERIZATION. OF THE LOBULES (SEE COMMENT). -LYMPH NODES : TWO NODES NEGATIVE FOR TUMOR (ONE SENTINEL, ONE WITH. THE BREAST BIOPSY ITSELF, SEE COMMENT) . -MULTICENTRICITY: ABSENT. -ESTROGEN RECEPTORS : POSITIVE (>10%). - PROGESTERONE RECEPTORS : NEGATIVE. -HER 2 NEU BY IHC: POSITIVE (3+). - -PATHOLOGIC STAGE: pT2 NO MX. -AJCC STAGE: IN THE ABSENCE OF METASTASES : IIA. B. SENTINEL LYMPH NODE, LEFT AXILLARY, EXCISION: -ONE LYMPH NODE NEGATIVE FOR MALIGNANCY. - IMMUNOHISTOCHEMICAL MARKER FOR CYTOKERATIN CONFIRMS THIS NODE. IS NEGATIVE FOR MALIGNANCY. COMMENT: The there tumor, is cancerization measured grossly, of the is lobules 3.1 cm which in greatest extends dimension. up to 1.5 However cm beyond. the grossly recognizable mass of invasive tumor. ER, PR and Her 2 studies were performed on the previous core biopsy,. the results are copied into this report, but these studies. lave not been repeated. Specimen #: FINAL DIAGNOSIS (continued) : Two lymph nodes are identified, both negative for malignancy. One lymph. node is present in the breast parenchyma and is the nodule identified. grossly near the inferior margin. The second one is the sentinel node in. specimen "B". This case has undergone intradepartmental review and the above diagnosis. has been agreed upon. CLINICAL DIAGNOSIS AND HISTORY: year old white female with left breast cancer. GROSS DESCRIPTION: A. Received fresh labeled with patient's name. designated. "LEFT BREAST LONG STITCH LATERAL, DOUBLE STITCH DEEP, SHORT STITCH. SUPERIOR" is a 230 gram irregular portion of breast tissue oriented. as follows short suture superior, long lateral and double deep. The. specimen measures 1.0 cm medial to lateral, 10.5 cm superior to inferior,. and 5.0 cm anterior to posterior and is inked as follows: superior. blue, inferior green, lateral yellow, medial red, anterior orange,. posterior black. Serial sectioning reveals a 2.7 x 3.1 x 2.5 cm centrally. located pink white firm gritty mass with well defined borders and comes. closest to the anterior margin (1. 0 cm). A second well circumscribed. tan white fibrous mass is noted at the inferior margin measuring 1. 1 x 0.9. x approximately 0.8 cm and comes to within approximately 0.4 cm of the. inferior green margin and comes to within 0.2 cm of the lateral yellow. margin. This mass is located approximately 1.2 cm from the larger mass. Remainder of cut surface is composed primarily of lobulated adipose tissue. admixed with scant fibrous tissue. No additional lesions identified. Representative sections submitted as follows: A1: mass and adjacent normal. A2: mass and adjacent normal. A3: normal, 1.0 cm from mass. Matched sections of A1-A3 and fresh/frozen tumor submitted for CBCP. protocol. Additional sections. A4- A5 inferior margin. A. Specimen #: GROSS DESCRIPTION (continued) : A6-A8 small nodule inferior margin. A9-A10: tissue from same plane sectioned in A2. All next plane of tissue. A12-A14: tissue from same plane as A1. A15: superior margin. 15CF. B. Received fresh labeled with patient's name. designated. " SENTINEL LYMPH NODE LEFT AXILLARY" consists of a single 1.0 x 0.8 x 0.4. cm pink tan lymph node with attached adipose tissue. Specimen is bisected. and one half submitted in B1 and remaining half submitted for CBCP. protocol.

expanded version (tokens=1512) : 
 Histological classification - Infiltrating Ductal Carcinoma, no special type.

Subtype - HER2 positive.

Description of any necrosis - Absent.

Tumor size - 3.1 cm in the greatest dimension.

Histological grade - Nottingham grade III/III (poorly differentiated).

Nuclear grade - Nottingham score of 8/9 (tubules=3, mitoses=2, nuclei=3).

Lymphovascular invasion - No unequivocal involvement.

Calcification - Absent.

Receptor status - Estrogen receptors positive (>10%), Progesterone receptors negative, HER2 positive (3+) by IHC.

Ancillary testing results - Two lymph nodes identified, both negative for malignancy. One lymph node present in the breast parenchyma and is the nodule identified grossly near the inferior margin. The second one is the sentinel node, which is negative for malignancy as confirmed by immunohistochemical marker for cytokeratin.

Comment - Intraductal component present with less than 25%, with prominent cancerization of the lobules. ER, PR and Her 2 studies were performed on the previous core biopsy, the results are copied into this report, but these studies have not been repeated. The case has undergone intradepartmental review and the above diagnosis has been agreed upon.

Clinical diagnosis and history - Left breast cancer in a white female.

Gross description - Received fresh labeled with the patient's

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=1665) : 
 Report: The left breast biopsy reveals a 3.1 cm infiltrating ductal carcinoma, HER2 positive with no necrosis and absent calcification. The poorly differentiated carcinoma (Nottingham grade III/III) has a Nottingham score of 8/9. Estrogen receptors are positive (>10%), progesterone receptors are negative, and HER2 is positive (3+) by IHC. The tumor has no unequivocal lymphovascular invasion, margins are negative, and two lymph nodes are negative for malignancy.

